Email this article Use of melatonin in combined treatment for inflammatory bowel diseases
- Authors: Rakhimova O.Y.1, Rakhimova OY.2
-
Affiliations:
- City Clinical Hospital Twenty-Four, Moscow Healthcare Department
- Issue: Vol 82, No 12 (2010)
- Pages: 64-68
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30762
- ID: 30762
Cite item
Full Text
Abstract
Aim: to provide rationale for and develop treatment regimens using melatonin for inflammatory bowel diseases (IBD).
Subjects and methods. Prior to and 30 days after treatment, colonic mucosal biopsy specimens were studied by electron microscopy in 40 patients with Crohn's disease (CD) and ulcerative colitis (UC) in whom the diagnosis was verified by the examination and morphological study of the colonic mucosa. The patients were divided into 2 groups: 1) traditional pathogenetic therapy; 2) combined therapy using melatonin.
Results. Following 30-day therapy using melatonin, signs of inflammatory infiltration were absent in 77.8% of the patients with CD. Minor inflammatory infiltrates consisting mainly of lymphoid cells and solitary granulocytes persisted in the mucosa and submucosal layer in 44.4% of the CD patients receiving the therapy without melatonin. The surface of columnar cells exhibited villi in 77.8%; however, a brush border failed to form in all cells.
One month after therapy using melatonin, the ultrastructure of the colonic mucosa was normal in the patients with UC. Inflammatory infiltration and dystrophy were absent in 88.8% of cases. Small inflammatory infiltrates consisting of lymphocytes were seen in occasional mucosal portions in 50% of the melatonin-untreated patients with UC. There was focal plethora in the vessels.
Conclusion. The use of melatonin in combined therapy for IBD considerably improves the results of treatment and promotes a more complete ultrastructural recovery of the colonic mucosa.
Subjects and methods. Prior to and 30 days after treatment, colonic mucosal biopsy specimens were studied by electron microscopy in 40 patients with Crohn's disease (CD) and ulcerative colitis (UC) in whom the diagnosis was verified by the examination and morphological study of the colonic mucosa. The patients were divided into 2 groups: 1) traditional pathogenetic therapy; 2) combined therapy using melatonin.
Results. Following 30-day therapy using melatonin, signs of inflammatory infiltration were absent in 77.8% of the patients with CD. Minor inflammatory infiltrates consisting mainly of lymphoid cells and solitary granulocytes persisted in the mucosa and submucosal layer in 44.4% of the CD patients receiving the therapy without melatonin. The surface of columnar cells exhibited villi in 77.8%; however, a brush border failed to form in all cells.
One month after therapy using melatonin, the ultrastructure of the colonic mucosa was normal in the patients with UC. Inflammatory infiltration and dystrophy were absent in 88.8% of cases. Small inflammatory infiltrates consisting of lymphocytes were seen in occasional mucosal portions in 50% of the melatonin-untreated patients with UC. There was focal plethora in the vessels.
Conclusion. The use of melatonin in combined therapy for IBD considerably improves the results of treatment and promotes a more complete ultrastructural recovery of the colonic mucosa.
Keywords
About the authors
Ol'ga Yur'evna Rakhimova
Email: o-rakhimova@mail.ru
O Yu Rakhimova
City Clinical Hospital Twenty-Four, Moscow Healthcare DepartmentCity Clinical Hospital Twenty-Four, Moscow Healthcare Department
References
- Адлер Г. Болезнь Крона и язвенный колит: Пер. с нем. А. А. Шептулин. М.: ГЭОТАР-Медицина; 2001.
- Pearse A. G. E. The cytochemistry and ultrastructure of polypeptide hormoneproducing cell of the APUD series and the embryologic and pathologic implications of the concept. J. Histochem. Cytochem. 1969; 17: 303-313.
- Larsson L.-I. On the possible existence of multiple endocrine, paracrine and neurocrine messengers in secretory system. Invest. Cell Pathol. 1980; 3: 73-85.
- Raikhlin N. T., Kvetnoy I. M. The APUD system (Diffuse endocrine system) in normal and pathologica1 states. Physiol. Gen. Biol. Rev. 1994; 8: 1-44.
- Kvetnoy I. M., Sandvik A. K., Waldum H. L. The diffuse neuroendocrine system and extrapineal melatonin. J. Mol. Endocrinol. 1997; 18: 1-3.
- Raikhlin N. T., Kvetnoy I. M., Tolkachev V. N. Melatonin may be synthesised in enterochromoffine cell. Nature 1975; 155: 344-345.
- Raikhlin N. T., Kvetnoy I. M. Melatonin and enterochromoffine cell. Acta Histochem. 1976; 55: 19-25.
- Lee P. P., Pang S. F. Melatonin and its receptors in the gastrointestinal tract. Biol. Signals 1993; 2: 181-193.
- Solcia E., Usellini L. et al. Endocrin cell producing regulatory peptides. In: Regulatory Peptides. Basel; 1989. 220-246.
- Кветной И. М. APUD-система (структурно-функциональная организация, биологическое значение в норме и патологии). Успехи физиол. наук 1987; 18(1): 84-102.
- Осадчук М. А., Киричук В. Ф., Кветной И. М. Диффузная нейроэндокринная система: общепатологические и гастроэнтерологические аспекты. Саратов: Изд-во Саратов. ун-та; 1996.
- Bubenik G. A., Dhanvantari S. Influence of serotonin and melatonin on some parameters of gastrointestinal activity. J. Pineal Res. 1989; 7: 333-344.
- Girouard H. et al. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J. Hypetens. 2001; 19: 1369-1377.
- Shibata S. et al. Vasorelaxing action of melatonin in rabbit basilar artery. Gen. Pharmacol. 1989; 20: 677-680.
- Wajs E., Lewinski A. Melatonin and N-acetylserotonin - two pineal indoleamines inhibiting the proliferation of the jejunal epithelial cells in the rat. Med. Sci. Res. 1988; 16: 1125-1126.
- Zerek-Melen G., Lewinski A., Kulak J. The opposite effect of high and low doses of melatonin on mitotic activity of the mouse intestinal epithelium. Endokrynol. Po;. 1987; 38: 317- 323.
Supplementary files
